Lactose fermentation positive cells on MacConkey Agar.



Dao Nguyen MD Director of the Antimicrobial Resistance CentreDr. Dao Nguyen, MD, MSc. Founder and Director, McGill AMR Centre

Associate professor, Departments of Medicine, Microbiology and Immunology, Faculty of Medicine and Health Science

Scientist, Translational Research in Respiratory Diseases program, Research Institute of the McGill University Health Centre

Physician, Division of Respirology, McGill University Health Centre

FRQS Chercheur Boursier Clinicien, recipient of CIHR Clinician Scientist award, Vertex Cystic Fibrosis Research Innovation award, Cystic Fibrosis Scholar award and Burroughs Wellcome Fund Career Award for Medical Scientist.

Dr Nguyen’s multidisciplinary research bridges fundamental microbiology and translational research. It is focused on chronic bacterial infections and the biology of Pseudomonas aeruginosa, particularly the mechanisms of antibiotic tolerance and respiratory infections. She has expertise in bacteriology, biofilm biology, host-pathogen interactions, and cellular and murine models of infection. She has collaborated with academic groups from a wide range of disciplines and with the anti-infective biotechnology industry to advance the discovery of novel antibacterial and adjuvant therapies and antimicrobial biomaterials. Since 2020, she has spearheaded the creation of the new AMR Centre and leads its current activities.

Associate Directors

Makeda SemretDr. Makeda Semret, MD, FRCP(C). Associate director, McGill AMR Centre

Associate professor, Departments of Medicine, Infectious Diseases, Faculty of Medicine and Health Science, McGill University

Director, Training Program in Infectious Diseases and Medical Microbiology, McGill University

Lead, Antimicrobial Stewardship Program, McGill University Health Centre

Founder and co-director, Addis Ababa University-McGill Partnership in Infectious Diseases

As the Lead for the Antimicrobial Stewardship Program, Dr Semret leads the development and dissemination of infectious diseases clinical management guidelines and the implementation of interventions to optimize antibiotic prescription quality at the MUHC, a quaternary care hospital. Her clinical research is focused on assessing interventions to inform clinical decision-making in infectious diseases, with a focus on common infections among hospitalized patients. She is the Canadian coordinator and co-PI of PILGRIM, a study led by an international consortium that aims to determine the differential impact of antimicrobial prescription quality and infection control practices on gut microbiota domination by healthcare-associated pathogens. She has served as site-PI and co-investigator of multicenter international randomized controlled trials assessing various therapeutic agents for management of COVID-19, and as scientific advisor for the Federal Government of Canada COVID-19 Therapeutics Task Force. As founder and co-director of the institutional partnership between Addis Ababa University and McGill (, and co-PI of the longest cohort study on Hospital-Associated infections and AMR in Ethiopia, she is currently working on implementing bacteriology diagnostics and stewardship interventions to optimize antimicrobial use and patient outcomes in Ethiopian hospitals.

Albert BerghuisDr. Albert Berghuis, PhD. Associate Director, McGill AMR Centre

Distinguished James McGill in the Departments of Biochemistry, Microbiology and Immunology, Faculty of Medicine and Health Science, McGill University

Chair, Department of Biochemistry, Faculty of Medicine and Health Science

Team leader, Chemical and Structural Biology, Life Science Complex. Former Canada Research Chair in Structural Biology (Tier 1).

Dr. Berghuis’ research focuses on the structural elucidation of protein-drug interactions, particularly bacterial proteins that confers antibiotic resistance. He has expertise structural biology including various complementary biophysical techniques such as X-ray diffraction/scattering and nuclear magnetic resonance spectroscopy. His work has informed the development of next-generation anti-infectives to overcome antibiotic resistance, and the design of adjuvants that enhance the effectiveness of antibiotics. He also serves on the editorial boards of several journals, has consulted for the biotech and pharmaceutical industry, participated in and chaired expert panels advising granting agencies (e.g. CIHR, CFI, NIH), and has been a member of various advisory boards (e.g. Physical Sciences Advisory Committee for the Canadian Space Agency).



Executive Committee

Marcel BehrMarcel Behr

Dept of Medicine (Faculty of Medicine and Health Sciences)








Bastien CastagnerBastien Castagner

Dept of Pharmacology & Therapeutics (Faculty of Medicine and Health Sciences)








Dominic FrigonDominic Frigon

Dept of Civil Engineering (Faculty of Engineering)








Samantha GruenheidSamantha Gruenheid

Dept of Microbiology and Immunology (Faculty of Medicine and Health Sciences)








Jennifer RonholmJennifer Ronholm

Dept of Food Science and Agricultural Chemistry/Animal Science (Faculty of Agricultural and Environmental Sciences)

Back to top